Scott Andrew Smith Bio Atla, Inc. (BCAB) insider trading activity

Scott Andrew Smith is of BioAtla, Inc.. Currently has a direct ownership of 321,550 shares of BCAB, which is worth approximately $122,189. The most recent transaction as insider was on Sep 30, 2022, when has been sold 1,791 shares (Common Stock) at a price of $7.7 per share, resulting in proceeds of $13,791. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 322K

7.88% 3M change

6.33% 12M change

Total Value Held $122,189

Scott Andrew Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2022	SELL Payment of exercise price or tax liability	$13,791 $7.7 p/Share	1,791 Reduced 0.55%	326,253 Common Stock
Aug 31 2022	SELL Payment of exercise price or tax liability	$15,600 $8.71 p/Share	1,791 Reduced 0.54%	328,044 Common Stock
Jul 31 2022	SELL Payment of exercise price or tax liability	$6,089 $3.4 p/Share	1,791 Reduced 0.54%	329,835 Common Stock
Jun 30 2022	SELL Payment of exercise price or tax liability	$5,104 $2.85 p/Share	1,791 Reduced 0.54%	331,626 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$4,316 $2.41 p/Share	1,791 Reduced 0.53%	333,417 Common Stock
Apr 30 2022	SELL Payment of exercise price or tax liability	$6,233 $3.48 p/Share	1,791 Reduced 0.53%	335,208 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$8,955 $5.0 p/Share	1,791 Reduced 0.53%	336,999 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$11,606 $6.48 p/Share	1,791 Reduced 0.53%	338,790 Common Stock
Jan 31 2022	SELL Payment of exercise price or tax liability	$20,850 $9.56 p/Share	2,181 Reduced 0.64%	340,581 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$56,809 $19.63 p/Share	2,894 Reduced 0.84%	342,762 Common Stock
Dec 02 2021	SELL Open market or private sale	$65,976 $22.11 p/Share	2,984 Reduced 0.86%	345,656 Common Stock
Dec 01 2021	SELL Open market or private sale	$14,588 $23.23 p/Share	628 Reduced 0.18%	348,640 Common Stock
Nov 30 2021	SELL Open market or private sale	$11,802 $24.69 p/Share	478 Reduced 0.14%	349,268 Common Stock
Nov 29 2021	SELL Open market or private sale	$9,532 $23.89 p/Share	399 Reduced 0.11%	349,746 Common Stock
Nov 24 2021	SELL Open market or private sale	$11,622 $24.94 p/Share	466 Reduced 0.13%	350,145 Common Stock
Nov 23 2021	SELL Open market or private sale	$17,216 $25.17 p/Share	684 Reduced 0.19%	350,611 Common Stock
Nov 22 2021	SELL Open market or private sale	$11,279 $26.23 p/Share	430 Reduced 0.12%	351,295 Common Stock
Oct 01 2021	SELL Open market or private sale	$90,359 $30.18 p/Share	2,994 Reduced 0.84%	351,725 Common Stock
Aug 26 2021	SELL Open market or private sale	$1,338,403 $40.26 p/Share	33,244 Reduced 8.57%	354,719 Common Stock
Jun 14 2021	BUY Other acquisition or disposition	-	34,963 Added 8.27%	387,963 Common Stock

Also insider at

VTRS

Viatris Inc Healthcare

Chief Executive Officer

BCAC

Brookline Capital Acquisition Corp. Financial Services

Director

SAS